Safety of Tirofiban in Acute Ischemic Stroke: the SaTIS trial. Stroke. 218. Pancioli AM, Broderick J, Brott T, Tomsick T, Khoury J, Bean J, del Zoppo G, Kleindorfer D, Woo D, Khatri P, et al; CLEAR Trial Investigators. The combined approach to lysis utilizing eptifiba- tide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke. 219. Johnston SC, Amarenco P. Ticagrelor versus aspirin in acute stroke or transient ischemic attack. N Engl J Med. 2016;375:1395. doi: 220. Ciccone A, Motto C, Abraha I, Cozzolino F, Santilli I. Glycoprotein IIb- IIIa inhibitors for acute ischaemic stroke. Cochrane Database Syst Rev. 221. Adams HP Jr, Effron MB, Torner J, D valos A, Frayne J, Teal P, Leclerc J, Oemar B, Padgett L, Barnathan ES, et al; for the AbESTT-II Investigators. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). 222. Mokin M, Kass-Hout T, Kass-Hout O, Radovic V, Siddiqui AH, Levy EI, SnyderKV.Intravenousheparinforthetreatmentofintraluminalthrombus in patients with acute ischemic stroke: a case series. J Neurointerv Surg. 223. Vellimana AK, Kadkhodayan Y, Rich KM, Cross DT 3rd, Moran CJ, Zazulia AR, Lee JM, Chicoine MR, Dacey RG Jr, Derdeyn CP, et al. Symptomatic patients with intraluminal carotid artery thrombus: outcome with a strategy of initial anticoagulation. J Neurosurg. 2013;118:34 41. 224. Kate M, Gioia L, Buck B, Sivakumar L, Jeerakathil T, ShuaibA, Butcher K. Dabigatran therapy in acute ischemic stroke patients without atrial fibrillation. Stroke. 2015;46:2685 2687. doi: 10.1161/ Sisson A, Pandurengan R, Chen Z, et al. The Argatroban and Tissue-Type Plasminogen Activator Stroke Study: final results of a pilot safety study. 226. 